(Q42439025)

English

Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy.

scientific article published on March 2003

Statements

Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit